Research In Viral Eradication of HIV Reservoirs

NCT02336074 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Combination Antiretroviral Therapy (cART)
DRUG: Raltegravir
DRUG: Vorinostat
BIOLOGICAL: ChAdV63.HIVconsv (ChAd)
BIOLOGICAL: MVA.HIVconsv (MVA)

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]